Kim P. Kamdar

CIK 1535065 · last filed 2026-02-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$61.1K

Companies

6

Total Filings

35

Lifetime Open-Market Net

$12.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SERA Director 32,573 $1.87 $60.9K $0 5 2026-02-04
Singular Genomics Systems, Inc. (OMIC) Delisted Director 3,978,985 $20.01 $79.62M -$362.0K 5 2024-05-31
EVFM Director 19,287 $0.01 $158 $23.0K 8 2022-05-06
Vyome Holdings, Inc (OBLN) Delisted Director 27,148 $9.15 $248.4K $351.0K 9 2020-09-18
Evofem Biosciences, Inc. (NEOT) Delisted Director $0 4 2017-06-22
SNDX Director $18.25 $0 1 2016-11-02

Recent Filings · Page 4 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-11-02 SNDX Grant (A) $0 EDGAR
2016-10-14 Vyome Holdings, Inc (OBLN) Delisted Buy (P) +13,400 $201.0K EDGAR
2016-06-23 Evofem Biosciences, Inc. (NEOT) Delisted Grant (A) $0 EDGAR
2015-06-18 Evofem Biosciences, Inc. (NEOT) Delisted Grant (A) $0 EDGAR
2014-03-21 Disp (D) −27,500 -$385.0K
Showing 3135 of 35
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.